dolutegravir

PHD finger protein 5A ; Homo sapiens







5 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 29957545 Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA). 2018 Aug 2
2 25924475 [The in vitro HAART pharmacodynamics study with dolutegravir as the "anchor"]. 2015 Jan 1
3 25397500 Use of dolutegravir in two INI-experienced patients with multiclass resistance resulted in excellent virological and immunological responses. 2014 1
4 21381981 S/GSK1349572, a new integrase inhibitor for the treatment of HIV: promises and challenges. 2011 Apr 2
5 22101373 Implications of integrase inhibitors for HIV-infected transplantation recipients: raltegravir and dolutegravir (S/GSK 1349572). 2011 2